The emerging treatment of this peptide represents a exciting advance in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects dual pathways – GLP-1 and GIP – resulting in https://tirzepatide-peptide975471.blogrenanda.com/48973730/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment